+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures



Prevalence of vancomycin-resistant enterococcus in prenatal screening cultures



Journal of Clinical Microbiology 42(2): 855-857



Recommendations for the perinatal treatment of women colonized with Streptococcus agalactiae include vancomycin prophylaxis for those with severe penicillin allergies and antibiotic-resistant organisms. Because of potential postpartum infections due to vancomycin-resistant enterococci (VRE) and the possible spread of vancomycin resistance, the prevalence of VRE in prenatal screening cultures was determined.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050003450

Download citation: RISBibTeXText

PMID: 14766872

DOI: 10.1128/jcm.42.2.855-857.2004


Related references

Prevalence of vancomycin resistant Enterococcus species in prenatal screening cultures. Abstracts of the General Meeting of the American Society for Microbiology 103: C-413, 2003

Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infection Control and Hospital Epidemiology 32(9): 922-924, 2011

Low prevalence of vancomycin-resistant Enterococcus in dialysis outpatients with a history of vancomycin use. Peritoneal Dialysis International 16(6): 651-652, 1996

Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infection Control and Hospital Epidemiology 28(9): 1054-1059, 2007

Evaluation of a vancomycin control program in response to a high prevalence of vancomycin resistant Enterococcus in a university hospital. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 37: 303, 1997

Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India. Indian Journal of Medical Microbiology 34(1): 38-45, 2016

Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis. American Journal of Infection Control 38(5): 406-409, 2010

Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faecium. Journal of Clinical Microbiology 36(8): 2333-2335, 1998

Relationship of the incidence of vancomycin-resistant Enterococcus faecium and vancomycin-sensitive Enterococcus faecium Evidence for enhanced pathogenicity due to vancomycin-resistance. Abstracts of the General Meeting of the American Society for Microbiology 95: 111, 1995

Hospital demographics and prevalence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Pharmacotherapy 22(10): 1349, 2002

Increasing prevalence of vancomycin-resistant Enterococcus faecium, expanded-spectrum cephalosporin-resistant Klebsiella pneumoniae, and imipenem-resistant Pseudomonas aeruginosa in Korea: KONSAR study in 2001. Journal of Korean Medical Science 19(1): 8, 2004

Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology 39(7): 2729-2731, 2001

Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country. American Journal of Infection Control 44(4): E45-E49, 2016

Use of active surveillance cultures to control vancomycin-resistant Enterococcus. Clinical Infectious Diseases 37(10): 1400-2; Author Reply 1402-3, 2003

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant e. 2013